Free Trial

Option Care Health (OPCH) Competitors

Option Care Health logo
$20.76 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$20.77 +0.01 (+0.05%)
As of 06/12/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OPCH vs. FMS, BTSG, HIMS, PACS, and CAI

Should you buy Option Care Health stock or one of its competitors? MarketBeat compares Option Care Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Option Care Health include Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), PACS Group (PACS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Option Care Health compare to Fresenius Medical Care AG & Co. KGaA?

Option Care Health (NASDAQ:OPCH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

In the previous week, Option Care Health had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 7 mentions for Option Care Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Option Care Health's average media sentiment score of 1.46 beat Fresenius Medical Care AG & Co. KGaA's score of 0.61 indicating that Option Care Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Option Care Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Option Care Health's net margin of 3.64%. Option Care Health's return on equity of 18.17% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Option Care Health3.64% 18.17% 7.16%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

98.1% of Option Care Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 1.7% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Option Care Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Option Care Health$5.65B0.58$207.59M$1.2916.09
Fresenius Medical Care AG & Co. KGaA$22.20B0.56$1.11B$1.9012.12

Option Care Health has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

Option Care Health currently has a consensus price target of $30.54, suggesting a potential upside of 47.10%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, suggesting a potential upside of 21.56%. Given Option Care Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Option Care Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Option Care Health
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Summary

Option Care Health beats Fresenius Medical Care AG & Co. KGaA on 12 of the 17 factors compared between the two stocks.

How does Option Care Health compare to BrightSpring Health Services?

Option Care Health (NASDAQ:OPCH) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

In the previous week, BrightSpring Health Services had 8 more articles in the media than Option Care Health. MarketBeat recorded 15 mentions for BrightSpring Health Services and 7 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.46 beat BrightSpring Health Services' score of 1.14 indicating that Option Care Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Option Care Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.1% of Option Care Health shares are held by institutional investors. 1.7% of Option Care Health shares are held by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Option Care Health has a net margin of 3.64% compared to BrightSpring Health Services' net margin of 2.27%. Option Care Health's return on equity of 18.17% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Option Care Health3.64% 18.17% 7.16%
BrightSpring Health Services 2.27%14.63%4.41%

Option Care Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market.

Option Care Health currently has a consensus price target of $30.54, indicating a potential upside of 47.10%. BrightSpring Health Services has a consensus price target of $58.53, indicating a potential downside of 7.43%. Given Option Care Health's higher probable upside, analysts plainly believe Option Care Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Option Care Health
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

Option Care Health has higher earnings, but lower revenue than BrightSpring Health Services. Option Care Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Option Care Health$5.65B0.58$207.59M$1.2916.09
BrightSpring Health Services$13.65B0.91$190.67M$1.4144.84

Summary

BrightSpring Health Services beats Option Care Health on 10 of the 17 factors compared between the two stocks.

How does Option Care Health compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

Option Care Health has a net margin of 3.64% compared to Hims & Hers Health's net margin of -0.56%. Option Care Health's return on equity of 18.17% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Option Care Health 3.64%18.17%7.16%

Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 98.1% of Option Care Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 12 more articles in the media than Option Care Health. MarketBeat recorded 19 mentions for Hims & Hers Health and 7 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.46 beat Hims & Hers Health's score of 0.66 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
7 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 6.89%. Option Care Health has a consensus target price of $30.54, indicating a potential upside of 47.10%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.06
Option Care Health
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64

Option Care Health has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B2.65$128.37M-$0.09N/A
Option Care Health$5.65B0.58$207.59M$1.2916.09

Summary

Option Care Health beats Hims & Hers Health on 13 of the 17 factors compared between the two stocks.

How does Option Care Health compare to PACS Group?

PACS Group (NYSE:PACS) and Option Care Health (NASDAQ:OPCH) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

PACS Group has a net margin of 4.49% compared to Option Care Health's net margin of 3.64%. PACS Group's return on equity of 26.47% beat Option Care Health's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Option Care Health 3.64%18.17%7.16%

Option Care Health has higher revenue and earnings than PACS Group. Option Care Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.09$191.54M$1.5623.33
Option Care Health$5.65B0.58$207.59M$1.2916.09

PACS Group presently has a consensus price target of $48.00, indicating a potential upside of 31.89%. Option Care Health has a consensus price target of $30.54, indicating a potential upside of 47.10%. Given Option Care Health's higher possible upside, analysts plainly believe Option Care Health is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Option Care Health
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64

98.1% of Option Care Health shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 1.7% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Option Care Health had 5 more articles in the media than PACS Group. MarketBeat recorded 7 mentions for Option Care Health and 2 mentions for PACS Group. Option Care Health's average media sentiment score of 1.46 beat PACS Group's score of 0.43 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Option Care Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Option Care Health beats PACS Group on 9 of the 16 factors compared between the two stocks.

How does Option Care Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Option Care Health (NASDAQ:OPCH) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

98.1% of Option Care Health shares are owned by institutional investors. 50.0% of Caris Life Sciences shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Caris Life Sciences and Caris Life Sciences both had 7 articles in the media. Option Care Health's average media sentiment score of 1.46 beat Caris Life Sciences' score of 0.73 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Caris Life Sciences
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
3 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Caris Life Sciences has a net margin of 3.75% compared to Option Care Health's net margin of 3.64%. Caris Life Sciences' return on equity of 98.28% beat Option Care Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Caris Life Sciences3.75% 98.28% 48.87%
Option Care Health 3.64%18.17%7.16%

Caris Life Sciences currently has a consensus target price of $27.56, indicating a potential upside of 53.34%. Option Care Health has a consensus target price of $30.54, indicating a potential upside of 47.10%. Given Caris Life Sciences' higher possible upside, analysts clearly believe Caris Life Sciences is more favorable than Option Care Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caris Life Sciences
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Option Care Health
1 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.64

Option Care Health has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caris Life Sciences$812.03M6.26-$68.09M-$7.61N/A
Option Care Health$5.65B0.58$207.59M$1.2916.09

Summary

Option Care Health beats Caris Life Sciences on 9 of the 15 factors compared between the two stocks.

Get Option Care Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPCH vs. The Competition

MetricOption Care HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.26B$5.70B$6.53B$12.05B
Dividend YieldN/A1.54%2.67%5.66%
P/E Ratio16.0935.0623.9924.42
Price / Sales0.5822.17511.38110.47
Price / Cash10.1616.6027.4837.92
Price / Book2.483.1210.656.82
Net Income$207.59M$218.81M$3.57B$337.56M
7 Day Performance3.39%3.25%0.58%1.17%
1 Month Performance6.35%1.31%1.54%3.16%
1 Year Performance-34.30%14.98%25.40%30.58%

Option Care Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPCH
Option Care Health
4.9265 of 5 stars
$20.76
flat
$30.54
+47.1%
-34.3%$3.26B$5.65B16.098,266
FMS
Fresenius Medical Care AG & Co. KGaA
4.2755 of 5 stars
$21.79
-1.1%
$28.00
+28.5%
-19.5%$11.90B$22.20B11.471,488
BTSG
BrightSpring Health Services
4.2209 of 5 stars
$59.22
+3.2%
$58.53
-1.2%
+198.5%$11.32B$13.65B42.0023,500
HIMS
Hims & Hers Health
3.2953 of 5 stars
$27.08
+3.4%
$28.70
+6.0%
-51.5%$6.06B$2.35BN/A2,442
PACS
PACS Group
3.8701 of 5 stars
$35.17
-5.0%
$48.00
+36.5%
+250.9%$5.86B$5.29B22.5447,455

Related Companies and Tools


This page (NASDAQ:OPCH) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners